ANJESO (nda210583)- (30MG/ML (30MG/ML))

Generic Name	MELOXICAM	Innovator	BAUDAX
Dosage	30MG/ML (30MG/ML)
ParaIV Filing	No	505(b)2 Filing	Yes
Last Patent Expiry	2039-Mar-08	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2023-Feb-20
GAIN Expiry	None	Drug Complexity	No
Indication	ANJESO is an NSAID indicated for use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID analgesics.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	4

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
30MG/ML (30MG/ML)	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of ANJESO